Skip to main content
Jinoos Yazdany, MD, Rheumatology, San Francisco, CA, UCSF Medical Center

JinoosYazdanyMDMPH

Rheumatology San Francisco, CA

Associate Professor, Medicine, UCSF School of Medicine

Dr. Yazdany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yazdany's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Rheumatology, 2003 - 2006
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2025
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Accurate Measurement in California’s Safety-Net Health Systems Has Gaps and Barriers  
    Jinoos Yazdany, Urmimala Sarkar, Elaine C Khoong, Health Affairs
  • Psychometric Evaluation of the NIH Patient‐Reported Outcomes Measurement Information System (PROMIS®) in a Multi‐Racial, Multi‐Ethnic Systemic Lupus Erythematosus (SLE...  
    Jinoos Yazdany, Lindsey A Criswell, Arthritis Care & Research
  • Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D  
    Jinoos Yazdany, MD, JAMA
  • Join now to see all

Press Mentions

  • AI Is Changing Medicine: This Is How We Make Sure It Works for Everyone
    AI Is Changing Medicine: This Is How We Make Sure It Works for EveryoneJune 27th, 2022
  • AI Is Transforming Medicine: Here’s How We Make Sure It Works for Everyone
    AI Is Transforming Medicine: Here’s How We Make Sure It Works for EveryoneJune 26th, 2022
  • Risk of Adverse Outcomes Due to COVID-19 May Be Lower with TNF Inhibitor Monotherapy
    Risk of Adverse Outcomes Due to COVID-19 May Be Lower with TNF Inhibitor MonotherapyMay 5th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Farsi

Hospital Affiliations